Clear Street’s HeartSciences Inc Warrant HSCSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.8K Hold
270,770
﹤0.01% 815
2025
Q4
$19K Hold
270,770
﹤0.01% 725
2025
Q3
$37.6K Buy
270,770
+300
+0.1% +$32 ﹤0.01% 561
2025
Q2
$19K Sell
270,470
-300
-0.1% -$22 ﹤0.01% 461
2025
Q1
$10.9K Hold
270,770
﹤0.01% 362
2024
Q4
$8.15K Buy
270,770
+891
+0.3% +$34 ﹤0.01% 369
2024
Q3
$11.8K Hold
269,879
﹤0.01% 363
2024
Q2
$9.12K Buy
269,879
+3,615
+1% +$137 ﹤0.01% 441
2024
Q1
$13.3K Sell
266,264
-200
-0.1% -$13 ﹤0.01% 367
2023
Q4
$13.3K Hold
266,464
﹤0.01% 329
2023
Q3
$13.3K Buy
266,464
+49,437
+23% +$5.44K ﹤0.01% 481
2023
Q2
$34.1K Buy
217,027
+74,404
+52% +$13.3K ﹤0.01% 499
2023
Q1
$31.3K Buy
142,623
+85,877
+151% +$20.6K ﹤0.01% 311
2022
Q4
$16K Buy
56,746
+17,221
+44% +$5.75K ﹤0.01% 425
2022
Q3
$0 Buy
39,525
+39,025
+7,805% +$23.8K ﹤0.01% 1201
2022
Q2
$0 Buy
+500
New +$231 ﹤0.01% 1036

Other funds holding HSCSW

Clear Street's HSCSW Position: Q1 2026 in Review

Clear Street held its HeartSciences Inc Warrant (HSCSW) position steady in Q1 2026 at 270,770 shares worth $31.8K. The position accounts for ﹤0.01% of the portfolio, ranked #815.

Clear Street first reported a position in HSCSW in Q2 2022 and has held it in 16 quarters since. The position peaked at $37.6K in Q3 2025. 3 funds tracked by Wall St. Rank hold HSCSW as of Q1 2026.

  • Clear Street held 270,770 shares of HeartSciences Inc Warrant worth $31.8K as of Q1 2026.
  • Clear Street left its HeartSciences Inc Warrant share count unchanged in Q1 2026.
  • HeartSciences Inc Warrant made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #815 holding.
  • Clear Street first reported a position in HeartSciences Inc Warrant in Q2 2022 and has held it in 16 quarters since.
  • Clear Street's HeartSciences Inc Warrant position peaked at $37.6K in Q3 2025.
  • 3 funds tracked by Wall St. Rank held HeartSciences Inc Warrant as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.